Condensed interim consolidated statements of operations and comprehensive loss (USD $)	3 Months Ended		9 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Net revenues	$ 46,843,965	$ 47,129,641	$ 151,379,855	$ 157,370,449
Cost of revenues	(51,906,863)	(43,536,733)	(146,281,685)	(139,332,170)
Gross profit	(5,062,898)	3,592,908	5,098,170	18,038,279
Operating expenses:
Research and development expenses	(1,613,275)	(1,838,866)	(4,705,354)	(5,416,345)
Sales and marketing expenses	(2,256,661)	(2,042,334)	(5,967,227)	(6,514,482)
General and administrative expenses	(11,924,301)	(5,042,344)	(24,825,786)	(15,071,001)
Impairment charge	(3,616,508)	0	(6,324,194)	0
Total operating expenses	(19,410,745)	(8,923,544)	(41,822,561)	(27,001,828)
Operating loss	(24,473,643)	(5,330,636)	(36,724,391)	(8,963,549)
Finance costs, net	(2,799,237)	(2,710,601)	(8,316,395)	(8,062,563)
Government grant income	19,507	404,755	2,029,488	1,042,495
Other income	(68,052)	391,184	363,927	681,409
Loss before income taxes	(27,321,425)	(7,245,298)	(42,647,371)	(15,302,208)
Income tax benefits / (expenses)	(274,636)	0	(2,396,492)	315,558
Net loss	(27,596,061)	(7,245,298)	(45,043,863)	(14,986,650)
Other comprehensive income
- Foreign currency translation adjustment	(1,054,313)	2,123,058	804,518	5,401,668
Comprehensive loss	$ (28,650,374)	$ (5,122,240)	$ (44,239,345)	$ (9,584,982)
Net loss per share:
- Basic	$ (0.44)	$ (0.12)	$ (0.71)	$ (0.24)
- Diluted	$ (0.44)	$ (0.12)	$ (0.71)	$ (0.24)
Weighted average number of shares of common stock:
- Basic	63,095,246	62,895,246	63,095,246	62,895,164
- Diluted	63,095,246	62,895,246	63,095,246	62,895,164